查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1826912

2025年糖尿病診斷全球市場報告

Diabetes Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，糖尿病診斷市場規模強勁成長，從2024年的253.9億美元增至2025年的273.1億美元，複合年成長率為7.6%。預測期內的成長歸因於糖尿病盛行率的上升、老年人口的擴大、久坐生活方式的增加、微創診斷技術的普及以及肥胖盛行率的上升。

預計未來幾年糖尿病診斷市場規模將強勁成長，2029年將達到364.2億美元，複合年成長率為7.5%。預測期內的成長可歸因於胰島素幫浦普及率的提高、糖尿病技術的不斷進步、不健康生活方式的日益盛行、1型和2型糖尿病盛行率的飆升以及醫療保健基礎設施的不斷擴展。預測期內的主要趨勢包括生物感測器技術的進步、技術進步、診斷技術的進步、個人化和標靶治療醫療以及體外診斷技術的進步。

糖尿病診斷包括透過測量血糖值和其他相關生物標記來檢測和監測糖尿病的程序和測試。這些測試有助於識別異常的葡萄糖代謝，評估糖尿病的風險或存在情況，並制定早期檢測、疾病管理和治療計劃。

糖尿病診斷的主要產品類型包括血糖儀、連續血糖監測設備、採血針和試紙。血糖儀是攜帶式醫療設備，透過分析試紙上的少量血液（通常取自指尖）來測量血糖值。這些設備可用於各種環境，包括醫院、診斷中心和居家醫療，以檢測第1型糖尿病、第2型糖尿病和妊娠糖尿病。

2025年美國關稅及由此引發的貿易緊張局勢正對醫療保健產業產生重大影響，尤其是基本醫療設備、診斷設備和藥品的供應。醫院和醫療機構正疲於應對進口手術器械、診斷影像系統以及注射器和導管等消耗品不斷上漲的成本，而這些產品在國內的替代品有限。這些成本上漲給醫療保健預算帶來了巨大壓力，導致一些醫療機構推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，造成供應鏈延遲。為此，該行業正在採取多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供糖尿病診斷市場統計數據，例如全球市場規模、區域佔有率、糖尿病診斷市場佔有率的競爭對手、詳細的糖尿病診斷細分市場、市場趨勢以及糖尿病診斷行業的商機。本糖尿病診斷市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的全方位觀點。

未來五年7.5%的成長率預測比我們先前的預測略有下降，下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。關稅上漲可能會增加美國實驗室從瑞典和荷蘭採購的高效液相層析(HPLC)分析儀和校準標準品的成本，從而加劇糖尿病篩檢成本並延遲檢測結果。由於互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響，關稅上漲的影響可能更為廣泛。

肥胖症的日益流行預計將在未來幾年推動糖尿病診斷市場的成長。肥胖的特徵是體內脂肪過度堆積，會增加罹患多種健康疾病的風險，包括心臟病和糖尿病。肥胖症發病率的上升與久坐不動的生活方式、加工食品和高熱量食品消費量增加、遺傳易感性以及體力活動減少等因素有關。糖尿病診斷在肥胖管理中發揮關鍵作用，它能夠以及早發現胰島素阻抗和葡萄糖代謝問題，從而及時干預，防止體重增加和相關的健康併發症。例如，2023 年 9 月，美國政府機構疾病管制與預防中心報告稱，2022 年有 22 個州的成人肥胖率達到或超過 35%，高於 2021 年的 19 個州。肥胖率的上升促進了糖尿病診斷市場的擴張。

糖尿病診斷市場的公司正在擴大其產品陣容，並專注於開發創新產品，例如妊娠糖尿病診斷工具，以滿足對妊娠糖尿病早期發現和管理日益成長的需求。這些工具包括醫療設備和測試，旨在檢測和監測孕婦的妊娠糖尿病，通常伴隨著血糖測試，例如口服葡萄糖耐受測試（OGTT），以評估身體在懷孕期間如何處理糖。例如，2024 年 8 月，奧地利生物技術公司 DirectSens GmbH 推出了 XpressGT RUO 試劑套件，這是一種用於檢測與胰島素抗性相關的疾病（例如妊娠糖尿病、子宮內膜異位症和肝病）的尖端生物感測器工具。該套件透過測量靜脈血液中的 2-羥基丁酸（2-HB）水平來快速提供結果，並與標準臨床分析儀相容。這項技術創新可以促進早期診斷並改善全球數百萬名患者的健康狀況。

2023年9月，美國醫療設備公司雅培實驗室有限公司（Abbott Laboratories Ltd.）收購了Bigfoot Biomedical Inc.，具體金額未揭露。此次收購旨在鞏固雅培在糖尿病護理領域的地位，擴展其輔理善瞬感（FreeStyle Libre）產品組合，並進一步推進其在互聯解決方案方面的發展，以實現更加個性化和精準的糖尿病管理。 Bigfoot Biomedical Inc.是一家總部位於美國的醫療科技公司，專注於打造創新的胰島素管理解決方案。

糖尿病診斷市場由提供胰島素敏感性和抗性測試、神經病變檢測服務、視網膜病變篩檢服務和糖尿病風險評估服務等服務的營業單位所獲得的收益所構成。市場價值包括服務提供者銷售的或包含在其服務產品中的任何相關商品的價值。糖尿病診斷市場還包括血糖監測設備、糖化血紅蛋白 (HbA1c)檢測套組和胰島素幫浦的銷售。該市場的價值是指“出廠價”，即商品製造商或創造者銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球糖尿病診斷：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球糖尿病診斷市場：成長率分析
  • 全球糖尿病診斷市場表現：規模與成長，2019-2024
  • 全球糖尿病診斷市場預測：規模與成長，2024-2029年，2034年
  • 全球糖尿病診斷：總目標市場（TAM）

第6章 市場細分

  • 全球糖尿病診斷市場（按產品類型、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 血糖儀
  • 連續血糖監測裝置
  • 《採血針》
  • 試紙
  • 其他
  • 全球糖尿病診斷市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 糖尿病I
  • II型糖尿病
  • 妊娠糖尿病
  • 全球糖尿病診斷市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診斷中心
  • 居家照護環境
  • 其他
  • 全球糖尿病診斷市場：血糖儀細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 傳統血糖監測儀
  • 智慧型血糖儀
  • 藍牙血糖監測儀
  • 全球糖尿病診斷市場：持續血糖監測設備細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 穿戴式CGM系統
  • 植入式CGM系統
  • 閃光血糖儀
  • 全球糖尿病診斷市場：採血針細分市場、類型、績效及預測（2019-2024、2024-2029、2034）
  • 免稍後採血針
  • 多用途採血針
  • 全球糖尿病診斷市場：試紙細分、類型、效能及預測（2019-2024、2024-2029、2034）
  • 標準試紙
  • 智慧試紙
  • 全球糖尿病診斷市場：其他細分市場、按類型、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • HbA1c 檢測檢測套組
  • 尿糖試紙
  • 血酮儀

第7章 區域和國家分析

  • 全球糖尿病診斷市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球糖尿病診斷市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 糖尿病診斷市場：競爭格局
  • 糖尿病診斷市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Novartis AG
  • 3M Company
  • Medtronic plc
  • Regeneron Pharmaceuticals Inc.
  • Carl Zeiss Meditec AG
  • Bausch & Lomb Incorporated
  • DexCom Inc
  • Santen Pharmaceutical Co. Ltd.
  • Topcon Corporation
  • Tandem Diabetes Care Inc
  • Ypsomed AG
  • LifeScan Inc
  • Nova Biomedical Corporation
  • Ascensia Diabetes Care Holdings AG
  • ARKRAY Inc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年糖尿病診斷市場：提供新機會的國家
  • 2029年糖尿病診斷市場：細分市場將帶來新機會
  • 2029年糖尿病診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r34033u

Diabetes diagnostics encompasses the methods and tests used to detect and monitor diabetes by measuring blood glucose levels and other relevant biomarkers. These assessments help identify abnormal glucose metabolism, assess diabetes risk or presence, and support early detection, disease management, and treatment planning.

The primary product types in diabetes diagnostics include blood glucose meters, continuous glucose monitoring devices, lancets, test strips, and others. Blood glucose meters are portable medical devices that measure blood sugar levels by analyzing a small drop of blood, usually from a fingertip, placed on a test strip. These devices are used for Type I diabetes, Type II diabetes, and gestational diabetes across various settings, including hospitals, diagnostic centers, home care, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The diabetes diagnostics market research report is one of a series of new reports from The Business Research Company that provides diabetes diagnostics market statistics, including the diabetes diagnostics industry global market size, regional shares, competitors with the diabetes diagnostics market share, detailed diabetes diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the diabetes diagnostics industry. This diabetes diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diabetes diagnostics market size has grown strongly in recent years. It will grow from $25.39 billion in 2024 to $27.31 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising prevalence of diabetes, expanding geriatric population, increase in sedentary lifestyles, increase in adoption of minimally invasive diagnostic, and rising prevalence of obesity.

The diabetes diagnostics market size is expected to see strong growth in the next few years. It will grow to $36.42 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to rising adoption of insulin pumps, increasing advancements in diabetes technology, rising in the adoption of unhealthy Lifestyles, surge in the prevalence of type 1 and type 2 diabetes, and expanding healthcare infrastructure. Major trends in the forecast period include advancements in biosensor technology, technological advancements, advancements in diagnostic technologies, personalized medicine and targeted therapies, and advanced technologies in in vitro diagnostic products.

The forecast of 7.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. labs by driving up the cost of High Performance Liquid Chromatography(HPLC) analyzers and calibration standards sourced from Sweden and the Netherlands, exacerbating diabetes screening costs and delaying test results. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of obesity is expected to drive the growth of the diabetes diagnostics market in the coming years. Obesity is characterized by excessive accumulation of body fat, which raises the risk of several health conditions, including heart disease and diabetes. The growing incidence of obesity is linked to factors such as sedentary lifestyles, higher consumption of processed and high-calorie foods, genetic predisposition, and reduced physical activity. Diabetes diagnostics play a crucial role in obesity management by identifying insulin resistance and glucose metabolism issues early, allowing for timely interventions to prevent weight gain and associated health complications. For example, in September 2023, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, 22 states had an adult obesity rate of 35% or higher, up from 19 states in 2021. This increasing obesity rate is contributing to the expansion of the diabetes diagnostics market.

Companies operating in the diabetes diagnostics market are focusing on developing innovative products, such as gestational diabetes diagnostic tools, to broaden their product offerings and meet the rising demand for early detection and management of diabetes during pregnancy. These tools include medical devices and tests designed to detect and monitor gestational diabetes in pregnant women, often involving blood glucose testing, such as the oral glucose tolerance test (OGTT), to evaluate how the body processes sugar during pregnancy. For instance, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, introduced the XpressGT RUO kit, a cutting-edge biosensor tool for detecting insulin resistance-related conditions, including gestational diabetes, endometriosis, and liver disease. This kit provides rapid results by measuring 2-hydroxybutyrate (2-HB) levels in venous blood and is compatible with standard clinical analyzers. This innovation is designed to facilitate early diagnostics, potentially improving health outcomes for millions of patients worldwide.

In September 2023, Abbott Laboratories Ltd., a US-based medical device company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. This acquisition aims to strengthen Abbott's position in diabetes care, expand its FreeStyle Libre portfolio, and advance its efforts in developing connected solutions for more personalized and precise diabetes management. Bigfoot Biomedical Inc. is a US-based medical technology company focused on creating innovative solutions for insulin management.

Major players in the diabetes diagnostics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, 3M Company, Medtronic plc, Regeneron Pharmaceuticals Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, DexCom Inc, Santen Pharmaceutical Co. Ltd., Topcon Corporation, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, Optos plc, Bioland Technology Ltd, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, and DarioHealth Corp.

North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in diabetes diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diabetes diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diabetes diagnostics market consists of revenues earned by entities by providing services such as insulin sensitivity and resistance testing, neuropathy testing services, retinopathy screening services, and diabetes risk assessment services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetes diagnostics market also includes sales of glucose monitoring devices, HbA1c testing kits, and insulin pumps. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetes Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetes diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diabetes diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diabetes diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Blood Glucose Meters; Continuous Glucose Monitoring Devices; Lancets; Test Strips; Other Product Types
  • 2) By Diabetes Type: Diabetes I; Diabetes II; Gestational Diabetes
  • 3) By End-User: Hospitals; Diagnostic Centers; Homecare Settings; Other End-Users
  • Subsegments:
  • 1) By Blood Glucose Meters: Traditional Blood Glucose Meters; Smart Blood Glucose Meters; Bluetooth-enabled Blood Glucose Meters
  • 2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems; Implantable CGM Systems; Flash Glucose Monitoring Devices
  • 3) By Lancets: Single-use Lancets; Multi-use Lancets
  • 4) By Test Strips: Standard Test Strips; Smart Test Strips
  • 5) By Other Product Types: Hemoglobin A1c Testing Kits; Urine Glucose Test Strips; Blood Ketone Meters
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; Bayer AG; Abbott Laboratories; Novartis AG; 3M Company; Medtronic plc; Regeneron Pharmaceuticals Inc.; Carl Zeiss Meditec AG; Bausch & Lomb Incorporated; DexCom Inc; Santen Pharmaceutical Co. Ltd.; Topcon Corporation; Tandem Diabetes Care Inc; Ypsomed AG; LifeScan Inc; Nova Biomedical Corporation; Ascensia Diabetes Care Holdings AG; ARKRAY Inc; Optos plc; Bioland Technology Ltd; PTS Diagnostics Inc; AgaMatrix Inc; Senseonics Holdings Inc; DarioHealth Corp.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diabetes Diagnostics Market Characteristics

3. Diabetes Diagnostics Market Trends And Strategies

4. Diabetes Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Diabetes Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Diabetes Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Diabetes Diagnostics Market Growth Rate Analysis
  • 5.4. Global Diabetes Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Diabetes Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Diabetes Diagnostics Total Addressable Market (TAM)

6. Diabetes Diagnostics Market Segmentation

  • 6.1. Global Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Meters
  • Continuous Glucose Monitoring Devices
  • Lancets
  • Test Strips
  • Other Product Types
  • 6.2. Global Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diabetes I
  • Diabetes II
  • Gestational Diabetes
  • 6.3. Global Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Homecare Settings
  • Other End-Users
  • 6.4. Global Diabetes Diagnostics Market, Sub-Segmentation Of Blood Glucose Meters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Blood Glucose Meters
  • Smart Blood Glucose Meters
  • Bluetooth-enabled Blood Glucose Meters
  • 6.5. Global Diabetes Diagnostics Market, Sub-Segmentation Of Continuous Glucose Monitoring Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wearable CGM Systems
  • Implantable CGM Systems
  • Flash Glucose Monitoring Devices
  • 6.6. Global Diabetes Diagnostics Market, Sub-Segmentation Of Lancets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-use Lancets
  • Multi-use Lancets
  • 6.7. Global Diabetes Diagnostics Market, Sub-Segmentation Of Test Strips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Test Strips
  • Smart Test Strips
  • 6.8. Global Diabetes Diagnostics Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemoglobin A1c Testing Kits
  • Urine Glucose Test Strips
  • Blood Ketone Meters

7. Diabetes Diagnostics Market Regional And Country Analysis

  • 7.1. Global Diabetes Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Diabetes Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diabetes Diagnostics Market

  • 8.1. Asia-Pacific Diabetes Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diabetes Diagnostics Market

  • 9.1. China Diabetes Diagnostics Market Overview
  • 9.2. China Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diabetes Diagnostics Market

  • 10.1. India Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diabetes Diagnostics Market

  • 11.1. Japan Diabetes Diagnostics Market Overview
  • 11.2. Japan Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diabetes Diagnostics Market

  • 12.1. Australia Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diabetes Diagnostics Market

  • 13.1. Indonesia Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diabetes Diagnostics Market

  • 14.1. South Korea Diabetes Diagnostics Market Overview
  • 14.2. South Korea Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diabetes Diagnostics Market

  • 15.1. Western Europe Diabetes Diagnostics Market Overview
  • 15.2. Western Europe Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diabetes Diagnostics Market

  • 16.1. UK Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diabetes Diagnostics Market

  • 17.1. Germany Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diabetes Diagnostics Market

  • 18.1. France Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diabetes Diagnostics Market

  • 19.1. Italy Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diabetes Diagnostics Market

  • 20.1. Spain Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diabetes Diagnostics Market

  • 21.1. Eastern Europe Diabetes Diagnostics Market Overview
  • 21.2. Eastern Europe Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diabetes Diagnostics Market

  • 22.1. Russia Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diabetes Diagnostics Market

  • 23.1. North America Diabetes Diagnostics Market Overview
  • 23.2. North America Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diabetes Diagnostics Market

  • 24.1. USA Diabetes Diagnostics Market Overview
  • 24.2. USA Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diabetes Diagnostics Market

  • 25.1. Canada Diabetes Diagnostics Market Overview
  • 25.2. Canada Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diabetes Diagnostics Market

  • 26.1. South America Diabetes Diagnostics Market Overview
  • 26.2. South America Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diabetes Diagnostics Market

  • 27.1. Brazil Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diabetes Diagnostics Market

  • 28.1. Middle East Diabetes Diagnostics Market Overview
  • 28.2. Middle East Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diabetes Diagnostics Market

  • 29.1. Africa Diabetes Diagnostics Market Overview
  • 29.2. Africa Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diabetes Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Diabetes Diagnostics Market Competitive Landscape
  • 30.2. Diabetes Diagnostics Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Diabetes Diagnostics Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. 3M Company
  • 31.3. Medtronic plc
  • 31.4. Regeneron Pharmaceuticals Inc.
  • 31.5. Carl Zeiss Meditec AG
  • 31.6. Bausch & Lomb Incorporated
  • 31.7. DexCom Inc
  • 31.8. Santen Pharmaceutical Co. Ltd.
  • 31.9. Topcon Corporation
  • 31.10. Tandem Diabetes Care Inc
  • 31.11. Ypsomed AG
  • 31.12. LifeScan Inc
  • 31.13. Nova Biomedical Corporation
  • 31.14. Ascensia Diabetes Care Holdings AG
  • 31.15. ARKRAY Inc

32. Global Diabetes Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetes Diagnostics Market

34. Recent Developments In The Diabetes Diagnostics Market

35. Diabetes Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Diabetes Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Diabetes Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Diabetes Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer